Anti-Cyclin E1 antibody [EPR194]
- KO Validated
- RabMAb
- Recombinant
- What is this?
4
(3 Reviews)
|
(24 Publications)
Knockout Tested Rabbit Recombinant Monoclonal Cyclin E1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 24 publications.
View Alternative Names
CCNE, CCNE1, G1/S-specific cyclin-E1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cyclin E1 antibody [EPR194] (AB133266)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling Cyclin E1 with purified ab133266 at 1/150 dilution (10 μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cyclin E1 antibody [EPR194] (AB133266)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling Cyclin E1 with Purified ab133266 at 1 : 1000 dilution (1.6μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- WB
Lab
Western blot - Anti-Cyclin E1 antibody [EPR194] (AB133266)
Western blot : Anti-CCNE1 antibody [EPR194] (ab133266) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab133266 was shown to bind specifically to CCNE1. A band was observed at 45 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in CCNE1 knockout cell line. To generate this image, wild-type and CCNE1 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Cyclin E1 antibody [EPR194] (ab133266) at 1/1000 dilution
Lane 1:
Wild-type HCT 116 cell lysate at 20 µg
Lane 2:
CCNE1 knockout HCT 116 cell lysate at 20 µg
Lane 3:
Wild-type MCF7 ab288560 cell lysate at 20 µg
Lane 4:
CCNE1 knockout MCF7 <a href='/en-us/products/cell-lines/human-ccne1-knockout-mcf7-cell-line-ab286303'>ab286303</a> cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 47 kDa
Observed band size: 45 kDa
false
- WB
Lab
Western blot - Anti-Cyclin E1 antibody [EPR194] (AB133266)
Western blot : Anti-CCNE1 antibody [EPR194] (ab133266) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab133266 was shown to bind specifically to CCNE1. A band was observed at 47 kDa in wild-type MCF7 cell lysates with no signal observed at this size in CCNE1 knockout cell line ab286303 (knockout cell lysate ab300211). To generate this image, wild-type and CCNE1 knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Cyclin E1 antibody [EPR194] (ab133266) at 1/1000 dilution
Lane 1:
Wild-type MCF7 cell lysate at 20 µg
Lane 2:
CCNE1 knockout MCF7 cell lysate at 20 µg
Lane 3:
HT-29 cell lysate at 20 µg
Lane 4:
PC-3 cell lysate at 20 µg
Observed band size: 47 kDa
true
- WB
Lab
Western blot - Anti-Cyclin E1 antibody [EPR194] (AB133266)
Lanes 1 - 4 : Merged signal (red and green). Green - ab133266 observed at 47 kDa. Red - loading control, ab9484, observed at 37 kDa.
Unpurified ab133266 was shown to recognize Cyclin E1 in wild-type cells as signal was lost at the expected MW in Cyclin E1 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and Cyclin E1 knockout samples were subjected to SDS-PAGE. ab133266 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
Lane 1:
Western blot - Anti-Cyclin E1 antibody [EPR194] (ab133266) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-Cyclin E1 antibody [EPR194] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/cyclin-e1-antibody-epr194-bsa-and-azide-free-ab208695'>ab208695</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
Cyclin E1 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
MCF7 whole cell lysate at 20 µg
Observed band size: 47 kDa
false
- WB
Unknown
Western blot - Anti-Cyclin E1 antibody [EPR194] (AB133266)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Cyclin E1 antibody [EPR194] (ab133266) at 1/10000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Lane 2:
JAR (Human placenta choriocarcinoma epithelial cell) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 47 kDa
false
- ICC/IF
AbReview45361****
Immunocytochemistry/ Immunofluorescence - Anti-Cyclin E1 antibody [EPR194] (AB133266)
Unpurified ab133266 staining Cyclin E1 in HeLa cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde and permeabilized with 0.5% Triton X-100 in PBS. Samples were incubated with primary antibody (1/500 in PBS) for 1 hour at 22°C. ab150081, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG polyclonal (1/200) was used as the secondary antibody. Counterstained with DAPI.
This image is courtesy of an Abreview submitted by Kirk McManus
- WB
Unknown
Western blot - Anti-Cyclin E1 antibody [EPR194] (AB133266)
All lanes:
Western blot - Anti-Cyclin E1 antibody [EPR194] (ab133266) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
MCF7 cell lysate at 10 µg
Lane 3:
JAR cell lysate at 10 µg
Lane 4:
K562 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution
Predicted band size: 47 kDa
false
Related conjugates and formulations (7)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cyclin E1 antibody [EPR194]
-
Anti-Cyclin E1 antibody [EPR194] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Cyclin E1 antibody [EPR194]
-
660 APC
APC Anti-Cyclin E1 antibody [EPR194]
-
578 PE
PE Anti-Cyclin E1 antibody [EPR194]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cyclin E1 antibody [EPR194]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cyclin E1 antibody [EPR194]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (24)
Recent publications for all applications. Explore the full list and refine your search
Clinical, cosmetic and investigational dermatology 16:2119-2128 PubMed37581008
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed35883700
2022
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 52:102300 PubMed35430547
2022
Applications
Unspecified application
Species
Unspecified reactive species
BioFactors (Oxford, England) 48:135-147 PubMed34856026
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging cell 20:e13484 PubMed34612580
2021
Applications
Unspecified application
Species
Unspecified reactive species
Environmental health perspectives 129:77007 PubMed34328791
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical and biophysical research communications 557:228-235 PubMed33887588
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 10:530933 PubMed33505901
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 21:19 PubMed33407495
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 28:1333-1346 PubMed33168956
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com